EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 164 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $995,781 | -56.7% | 63,144 | -46.6% | 0.00% | – |
| Q2 2023 | $2,297,964 | -37.7% | 118,208 | -9.1% | 0.00% | – |
| Q1 2023 | $3,690,000 | +113229.2% | 130,063 | +16.7% | 0.00% | – |
| Q4 2022 | $3,256 | -99.9% | 111,415 | -51.9% | 0.00% | -100.0% |
| Q3 2022 | $6,125,000 | -32.7% | 231,806 | +13.2% | 0.00% | 0.0% |
| Q2 2022 | $9,101,000 | -23.0% | 204,847 | -14.2% | 0.00% | 0.0% |
| Q1 2022 | $11,815,000 | -4.8% | 238,739 | -2.1% | 0.00% | 0.0% |
| Q4 2021 | $12,412,000 | -32.8% | 243,746 | -26.4% | 0.00% | -50.0% |
| Q3 2021 | $18,480,000 | +25.0% | 331,298 | -4.1% | 0.00% | 0.0% |
| Q2 2021 | $14,787,000 | +415.6% | 345,475 | +402.7% | 0.00% | – |
| Q1 2021 | $2,868,000 | -18.5% | 68,722 | -9.0% | 0.00% | -100.0% |
| Q4 2020 | $3,518,000 | +33.6% | 75,535 | +20.1% | 0.00% | – |
| Q3 2020 | $2,633,000 | -14.9% | 62,873 | -2.5% | 0.00% | -100.0% |
| Q2 2020 | $3,094,000 | -1.7% | 64,491 | -5.7% | 0.00% | 0.0% |
| Q1 2020 | $3,146,000 | -31.3% | 68,394 | -10.3% | 0.00% | 0.0% |
| Q4 2019 | $4,581,000 | +1.2% | 76,269 | -4.7% | 0.00% | 0.0% |
| Q3 2019 | $4,526,000 | -16.6% | 80,002 | -18.9% | 0.00% | 0.0% |
| Q2 2019 | $5,428,000 | +2.5% | 98,688 | -5.9% | 0.00% | 0.0% |
| Q1 2019 | $5,296,000 | +122.5% | 104,899 | +77.6% | 0.00% | 0.0% |
| Q4 2018 | $2,380,000 | -45.9% | 59,078 | -7.0% | 0.00% | 0.0% |
| Q3 2018 | $4,402,000 | +69.6% | 63,504 | +85.2% | 0.00% | 0.0% |
| Q2 2018 | $2,595,000 | +1992.7% | 34,289 | +1352.9% | 0.00% | – |
| Q1 2018 | $124,000 | -2.4% | 2,360 | -0.6% | 0.00% | – |
| Q4 2017 | $127,000 | +370.4% | 2,374 | +417.2% | 0.00% | – |
| Q3 2017 | $27,000 | +440.0% | 459 | +270.2% | 0.00% | – |
| Q2 2016 | $5,000 | +25.0% | 124 | +39.3% | 0.00% | – |
| Q1 2016 | $4,000 | +300.0% | 89 | +790.0% | 0.00% | – |
| Q4 2015 | $1,000 | -99.6% | 10 | -99.8% | 0.00% | – |
| Q1 2015 | $278,000 | -87.7% | 6,630 | -96.3% | 0.00% | -100.0% |
| Q1 2014 | $2,265,000 | – | 177,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |